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Abstract.-
Background: Until recently, the mechanism for the malignant hyperthermia (MH) crisis
has been attributed solely to sustained massive Ca2+ release from the sarcoplasmic
reticulum  on  exposure  to  triggering  agents.  We now  investigate  the  role  of  TRPC
channels as an important contributor to the Ca2+ dyshomeostasis observed in MH. 
Methods: We  examined  the  mechanisms  responsible  for  Ca2+ dyshomeostasis  in
RYR1-pG2435R MH muscle cells using ion selective microelectrodes, Mn2+ quench of
Fura2 fluorescence, and western blots. 
Results: RYR1-pG2435R  MH  mouse  muscle  cells  show  gene  dose-dependent
increases in both [Ca2+]i and [Na
+]i and the rate of Mn
2+ quench on exposure to TRPC3/6
activators  oleoyl-acyl-sn-glycerol.  These  increases  were  inhibited  by  i) removal  of
extracellular  Ca2+ ii) the  nonspecific  sarcolemmal  cation  entry  blocker,  Gd3+ or  iii)
SAR7334,  which  specifically  blocks  TRPC6  and  TRPC3  mediated  cation  influx.
Furthermore,  local  pretreatment  with  SAR7334  partially  decreased  the  elevation  of
[Ca2+]i that is seen in MH muscles during exposure to isoflurane. Western blot analysis
showed  that  expression  of  TRPC3,  TRPC6 channels  was  significantly  increased  in
G2435R muscles in a gene dose-dependent manner, supporting their being the primary
molecular basis for increased sarcolemmal cation influx. 
Conclusions: Muscle  and  muscle  cells  in  knock-in  mice  expressing  the  RYR1-
pG2435R mutation are hypersensitive to TRPC3/6 activators oleoyl-acyl-sn-glycerol and
hyperforin:  this hypersensitivity can be negated with pharmacologic agents that block
TRPC3/6 activity.  This reinforces our working hypothesis  that TRPC  channels  play a
critical  role in causing intracellular  Ca2+ and Na+ overload in MH susceptible muscle,
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both at rest and during the MH crisis. 
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Introduction.- 
Malignant hyperthermia (MH) is an autosomal dominant hypermetabolic condition
triggered by volatile  anesthetics and depolarizing  neuromuscular  blockers1.  The MH
crisis  is  characterized  by  hypercapnia,  tachycardia,  hypoxemia,  muscle  rigidity,
hypermetabolism,  respiratory  and  metabolic  acidosis  and  hyperthermia.  Human
malignant  hyperthermia  susceptible  individuals  appear  to  for  the  most  part  remain
subclinical until challenged with pharmacologic triggering agents1-3. Once the syndrome
is triggered,  if  left  untreated,  the  mortality  of  a  fulminant  MH episode is  >70%, but
availability of dantrolene has reduced the mortality to <8%1,2. Molecular genetic studies
have established that the type 1 ryanodine receptor gene (RYR1) encoding the skeletal
muscle  sarcoplasmic  reticulum (SR)  Ca2+ release  channel  as  the  primary  locus  for
MH3-6. More than 200 RYR1 mutations found throughout the gene have been associated
with MH6. To date, one spontaneously occurring porcine model (R615C) and 4 murine
knock-in  models  expressing  the  murine  equivalent  of  human  (R163C7,  Y522S8,
G2434R9 and T4826I10 MH RYR1 mutations have been studied in detail. All 5 models
exhibit fulminant anesthetic--triggered MH episodes and heat intolerance with varying
gene dose relationships. The G2435R variant which is the focus of this study is a model
for  the most  frequent  variant  associated with  MH in  the  UK and North  America.  In
addition, this is the most common RYR1 variant to be associated with familial genotype-
phenotype discordance11. It is associated with a relatively weak IVCT phenotype and is
less likely  to  be associated with  an elevated serum CK compared with  T4826I  and
R163C12,13.
The  exact  molecular  mechanisms  by  which  RYR1 mutations  confer  MH
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susceptibility are unknown. A common characteristic of muscle expressing MH-RyR1
mutations compared to non-susceptible muscle is an increased resting intracellular Ca2+
concentration  ([Ca2+]i)  in  humans
14 and  animal  models15-18.  We  have  shown  that
exposure to halothane or isoflurane at clinically relevant concentrations causes [Ca2+]i to
rise several fold in MH muscle in one porcine and three murine experimental models,
whereas exposure to the same concentrations of halothane or isoflurane had no effect
in non-susceptible muscle17,19,20. 
Until  recently,  the mechanism for  the MH crisis  has been attributed solely to
massive self-sustaining release of Ca2+ from the SR on exposure to triggering agents.
Counter to this view, we have introduced a new paradigm that implicates nonspecific
sarcolemmal cation entry channels as both the predominant source of acutely elevated
intracellular calcium and sodium during fulminant MH and are significant contributors to
chronically elevated [Ca2+]i and [Na
+]i in quiescent MH-susceptible muscles
21,22. 
The objective of the current study was to test the hypothesis that TRPCs play a
major role in the Ca2+ dyshomeostasis that we recently described in a RYR1 pG2435R
knock-in murine model of MH9 and which were similar to our previous observations in
the  RYR1 pR163C  mouse21,22.  Here,  we  use  newly  available  more  specific
pharmacologic  agents  to  probe  TRPC  function  allowing  us  to  determine  their




Animals used in this study were housed in pathogen-free conditions with free
access to food, water and 12 hr light-and-dark cycles. All experiments were undertaken
with  either UK Home Office, University of California at Davis IACUC or Mount Sinai
Hospital IACUC approval. For single fiber and  in vivo studies a mixture of male and
female mice between 12-16 weeks were used and for myotube studies, myoblasts were
isolated from 10-12 day old neonatal mice. All experiments were terminal. For  in vivo
experiments the MH animals were allowed to succumb to isoflurane anesthesia when
this was used, otherwise they and all WT animals were euthanized under anesthesia by
cervical  dislocation. For muscle collection, MH and WT animals were euthanized by
cervical dislocation immediately prior to dissection. Because HOM animals were viable,
animals  were  obtained  and  allocated  to  HOM  and  HET  experimental  groups  by
selective breeding of HOM females to either HOM or WT C57BL/6J and animals were
used  as  available  in  the  breeding  colony  when  they  reached  the  appropriate  age.
Studies on WT mice were done on  3-5-month-old C57BL/6J  animals purchased from
Charles River Laboratories (Wilmington MA) or the St. James’s animal facility (Leeds,
UK) as needed.
Experimental Preparation
Experiments  were  conducted  at  room temperature  (~23oC):  (i)  in  vitro using
Flexor  digitorum  brevis  (FDB)  muscle  fibers  from  3-5-month-old  C57BL/6J  (WT),
heterozygous MH-G2435R (MH-HET) and homozygous MH-G2435R (MH-HOM) mice.
Single fibers were obtained by enzymatic digestion as described previously21. (ii) in vivo,
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in vastus lateralis fibers in WT and MH mice anesthetized with ketamine/xylazine (100/5
mg/kg body weight) as described previously22. (iii) in vitro using myotubes differentiated
from  myoblasts  from  C57BL/6  (WT),  heterozygous MH-p.G2435R  (MH-HET),  and
homozygous MH-p.G2435R (MH-HOM) mice as described in detail previously9. 
Ca2+
 
and Na+ selective microelectrodes 
Double-barreled  Ca2+  and  Na+ selective  microelectrodes  were  prepared  as
described previously14,22. Each  ion-selective microelectrode was individually calibrated
before  and  after  the  determination  of  intracellular  Ca2+ concentration  ([Ca2+]i)  and
intracellular Na+ concentration ([Na+]i) as described before22. Only those Ca2+ selective
microelectrodes with a linear relationship between pCa 3 and 7 (Nernstian response,
29.5 and 30.5 mV/pCa unit at 23°C and 37°C, respectively) were used experimentally.
The  Na+ selective  microelectrodes  gave  virtually  Nernstian  responses  at  free  [Na+]e
between 100 and 10 mM. However, although at concentrations between 10 and 1 mM
[Na+]e, the electrodes had a sub-Nernstian response (40–45 mV), their response was of
a sufficient amplitude to be able to measure [Na+]i. The sensitivity and response of the
Ca2+ and Na+ selective microelectrodes were not directly affected by any of the drugs
used in the present study. 
Ca2+
 
and Na+ determinations in muscle fibers 
Microelectrode  recordings  were  performed  as  described  previously22.  Single
isolated adult  flexor digitorum brevis muscle fibers (in vitro) or  vastus lateralis  muscle





-selective microelectrodes, and their potentials were recorded via
a high-impedance amplifier (WPI Duo 773 electrometer; WPI, Sarasota, FL, USA). The
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potential from the 3 M KCl microelectrode (Vm) was subtracted electronically from either
the  potential  of  the  Ca2+
 
electrode  (VCaE)  or  the  Na
+ electrode  (VNaE)  to  produce  a
differential  Ca2+- specific potential (VCa) or Na
+ -specific potential (VNa) that represents
the [Ca2+]i or [Na
+]i, respectively.  Vm, VCa, VNa were filtered (30–50 kHz) to improve the
signal-to-noise ratio and stored in a computer for further analysis. Data from any given
electrode impalement were accepted if Vm was >or = to -80mV, and if it was possible to
make a stable recording of either  Vm and VCa, or Vm and VNa for 60 seconds. These
criteria resulted in rejection of data from 20% of in vivo impalements and 30-35% of in
vitro impalements.
Measurements of Mn2+ quench of Fura 2 in myotubes and isolated single fibers.
When the Ca2+ indicator Fura2 is exposed to Mn2+ its fluorescence at its isobestic
emission wavelength is quenched. Because TRPC, Orai and slow voltage gated Ca2+
channels are permeable to Mn2+ as well as Ca2+, the rate of Mn2+ quench can be used to
determine the rate of Ca2+ entry into a cell. 
We used Mn2+ quench to assess sarcolemmal divalent cation entry in myotubes
or isolated single adult muscle fibers loaded with 5 M Fura2-AM for 30 mins at 37C.
The solution containing the Fura2-AM was washed off and the cells maintained for 25
mins at room temperature to allow de-esterification and equilibration of the intracellular
Fura-2. The cells were observed through a 40x 1.3 NA objective on a Nikon Eclipse
T2000 epifluorescence microscope using an excitation wave-length of 360+/-5 nm (the
isosbestic wavelength of Fura-2 where the fluorescence of the dye is independent of the
Ca2+ free versus Ca2+ bound state), and the emission signal measured at 510+/-40 nm.
Images were captured with 2x2 binning at a rate of 5 fps using an intensified 12-bit
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digital intensified charge-coupled device (ORCA-ER) and IPLab software. Regions of
interest in individual cells were analysed using Image J software (NHLBI), with the data
exported to GraphPad Prism 7. Prism was used to fit linear regression models (y=mx+c)
for  the  basal  signal  in  imaging  buffer,  and  then  independently  in  Mn2+-containing
solutions  with  and  without  treatment  drugs.  The  specific  rate  of  Fura-2  quenching
induced  by  Mn2+ entry  was  calculated  by  subtracting  the  basal  slope  of  decline  of
fluorescence over  time from the slope during the application of Mn2+  buffer  (i.e.  net
slope) and is expressed as arbitrary fluorescence units (AFU) per second. The net slope
was calculated in the absence and presence of treatment drugs. Cells with a positive
net slope following the addition of Mn2+ buffer were excluded from analysis because this
indicated a technical problem with the measurement, for the same reason the slope of
the quench signal was normalised to zero when the net slope was positive following
treatment with a cation channel antagonist.
Western blot analysis of TRPC3 and TRPC6 expression.-
Gastrocnemius  muscles  from  all  genotypes  were  dissected,  minced,  and
homogenized  in  modified  radioimmunoassay  precipitation  assay (RIPA)  buffer.  Total
protein  concentration  was  determined  using  the  bicinchoninic  acid  (BCA)  method
(Thermo-Scientific,  MA,  USA).  Samples  of  whole  gastrocnemius  homogenate  were
prepared as described by Altamirano et al.  [18] and incubated overnight at 4°C with
primary antibodies: rabbit anti -TRPC3, dilution 1:2500 (ab51560; Abcam, MA, USA),
rabbit  anti  -TRPC6,  dilution 1:2500 (ab62461,  Abcam, MA,  USA),  human anti-actin,
dilution of 1:5000 (SC8432; Santa Cruz, CA, USA). All of these antibodies have been
validated  previously  by  different  research  groups  and  our  laboratory.  The  resolved
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bands were detected with a Storm 860 Imaging System (GE Bio-Sciences, NJ, USA).
Protein  levels  were  quantified  using  myImageAnalysis  software  (Thermo-Fisher
Scientific, MA, USA) and normalized to b-actin. 
Solutions 
The mammalian Ringer solution used for experiments using muscle fibers had
the following composition (in mM): 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 5 glucose, and 10
HEPES, pH 7.4. The imaging buffer used for the experiments with myotubes contained
(in mM): 133 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 5.5 glucose, and 10 HEPES, pH 7.4. In the
Mn2+ buffer the CaCl2 and MgCl2  were substituted with 0.5 mM MnCl2. The  Ca
2+ free
solution had the following composition (in mM): 140 NaCl, 5 KCl, 2 Mg Cl2, 1 EGTA, 5
glucose,  and  10  HEPES,  pH 7.4.  1-oleoyl-2-acetyl-sn-glycerol,  Gd3+,  SAR7334  and
hyperforin solutions were made by adding the desired concentration of the reagent to
the physiological or Mn2+ containing solutions. 
Statistics 
Neither randomization nor blinding of the investigator performing the test were
used  for  these  studies.  No  specific  power  calculation  was  conducted  prior  to
experimentation but the rationale for the sample sizes used was based on our previous
studies  using  this  and  other  animal  models  of  MH  with  the  same  and  different
pharmacologic interventions. All values of intracellular ion concentrations are expressed
as mean±SD, with N representing the number of mice used for the in vivo experiments,
and n representing the number of myotubes or muscle fibers in which measurements
were carried out. Statistical analysis for studies done on muscle fibers both in vitro and
in vivo was performed using 1-way between genotypes ANOVA with Tukey’s post-test
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for  multiple measurements to determine significance. Normal distribution of the data
was verified by histogram analysis. For studies of Mn2+ quench in myotubes, the results
were not normally distributed, and as a result are expressed as the median±interquartile
range. These results were analyzed using a  Kruskal-Wallis test with Dunn’s multiple
comparison  to  determine  significance.  p<0.05  was  accepted  as  the  minimum
confidence level for significance for all comparisons but the P values obtained for each
comparison  are  reported.  With  the  exception  of  the  myotube  Mn2+ quench  studies,
where positive quench data were excluded or normalized to zero as described above,
and muscle fiber data where the criteria for a successful measurement was not met
(based on either a depolarized membrane potential or lack of stable electrode recording




Resting [Ca2+]i and [Na
+]i 
Malignant  hyperthermia  is  characterized  by  an  intracellular  Ca2+ and  Na+
dyshomeostasis14,19,22,23.  Consequently,  [Ca2+]i or  [Na
+]i was  measured  in  quiescent
single  muscle  fibers  isolated  from  WT,  MH-HET,  and  MH-HOM cells  using  double-
barreled ion-specific microelectrodes. [Ca2+]i was 120±2 nM (n=8) in WT, while it was
156±11 nM (n=11) in HET,  and 275±15 nM (n=10) in HOM (p <0.001 for both) (Figure
1A). No statistically significant difference was noted in the resting membrane potential
among WT and MH-HET or MH-HOM muscle fibers. Likewise, [Na+]i was more elevated
in HET, and HOM fibers than that observed in WT fibers. [Na+]i was 8±0.1 mM (n=8) in
WT fibers, while it was 10±1 mM (n=9) in MH-HET and 14±0.6 mM (n=11) in MH-HOM
respectively (p <0.001 for both) (Figure 1A).
As previously reported similar differences for [Ca2+]i and [Na
+]i  were obtained in
the in-vivo measurements carried out on the vastus lateralis from WT and MH mice9. In
a new data set carried out for this study [Ca2+]i  in WT was 122±3 nM (n=15) compared
to  144±9  nM  (n=14)  and  259±31  nM  (n=18)  in  MH-HET and  MH-HOM  muscles
respectively (Figure 1B). [Na+]i was 8±0.1 mM (n=16) in WT compared to 9.5±1 mM
(n=16) and 12.9±1.5 mM (n=13) in MH-HET and MH-HOM  fibers respectively(p <0.001
compared to WT) (Figure 1B). 
Taken together, the results demonstrate that there is a comparable intracellular
Ca2+ and Na+ overload in both isolated RYR1-p.G2435R muscle cells and intact muscle
fibers  compared  to  WT and  that  resting  intracellular  ion  recordings  under  in  vitro
conditions recapitulate those found in vivo. 
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1-oleoyl-2-acetyl-sn-glycerol (OAG) induces an elevation of [Ca2+]i and [Na
+]i 
To  directly  investigate  the  effect  of  diacylglycerol  (DAG)  on  [Ca2+]i and  [Na
+]i
single  muscle  fibers  were  exposed  to  OAG,  a  membrane-permeable  diacylglycerol
analog which has been shown to activate transient receptor potential cation channel
subfamily C,  member 3 (TRPC3) and member 6 (TRPC6) channels24.  Incubation of
muscle fibers in OAG (100 μM) for 5 minutes produces an elevation of [Ca2+]i in all
genotypes.  In WT [Ca2+]i was  increased by  60%  (from 123±3 nM  (n=11) to  196±27
nM (n=13) p<0.001), in MH-HETs it was enhanced by 99% (from 153±11 nM (n=12) to
304±45 nM  (n=11) p<0.001) and in MH-HOMs it was elevated by 113% (from 251±25
nM (n=12) to 534±64 nM (n=13) p<0.001) (Figure 2A). 
Since the permeability  of  TRPCs is cation specific but  not  Ca2+ specific,  their
activation  could  also  increase  Na+ entry  and  [Na+]i.  Application  of  OAG  (100μM)
significantly elevated [Na+]i in all genotypes but its effect was greater in MH muscle cells
than in WT (Figure 2B). In WT incubation with OAG elevated [Na+]i by 19% (from 8±0.1
mM, n=10 to 9.4±0.7 mM, n=9, p<0.001) in MH-HET by 42% (from 10±0.5 mM, n=10) to
14.2±0.7  mM,  n=9,  p<0.001)  and in  MH-HOM by 50% (from 13.9±0.5  mM,  n=9 to
20.9±1.5 mM, n=10, p<0.001). 
These elevations of  [Ca2+]i and [Na
+]i induced by OAG were not  affected by the
voltage gated Ca2+  channel inhibitor nifedipine (10 µM) nor associated with changes in
resting membrane potential in either WT or MH muscle fibers (data not shown).
Removal of extracellular Ca2+ prevented [Ca2+]i increases induced by OAG.
In a different set of experiments, we explored the contribution of the Ca2+ influx
on [Ca2+]i elevation elicited by OAG. Single WT and MH muscle fibers were incubated
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for  5  min  in  Ca2+-free  solution  prior  to  OAG  (100µM)  treatment.  This  exposure
significantly reduced [Ca2+]i in all  genotypes but had a greater effect in MH than WT
(Figure 3). In WT fibers Ca2+-free solution reduced [Ca2+]i  from 123±4 nM (n=10) to
98±6 nM (n=12, p<0.001) while in MH-HET it was reduced from 161±26 nM (n=14) to
135±7 nM (n=12, p<0.001) and in MH-HOM from to 256±27 nM (n=12) to 176±17 nM
(n=14, p<0.001). In addition, the observed rise in [Ca2+]i elicited by OAG was completely
inhibited in both WT and MH muscle fibers in the absence of extracellular Ca2+ (Figure
3). 
Blocking  sarcolemmal  Ca2+ and Na+ entry  with  Gd3+ abolishes  the  increases in
[Ca2+]i and [Na
+]i elicited by OAG.
To gain further insight into molecular mechanisms for the increased sarcolemmal
Ca2+ and Na+  entry responsible for the elevation in [Ca2+]i and [Na
+]i  after exposure to
OAG, we measured [Ca2+]i  and [Na
+]i  in isolated single WT and MH muscle fibers
before and after incubation in Gd3+  and then in the presence of Gd3+, after exposure to
OAG (100µM). Pretreatment with Gd3+ (25 μM) significantly lowered [Ca2+]i and [Na
+]i  by
15% and by 8% respectively in WT by 20% by 15% respectively in MH-HET and by 27%
and 29% respectively in MH-HOM (Figure 4A and B). Furthermore, Gd3+  pretreatment
prevented any significant increase in [Ca2+]i and [Na
+]i during exposure to OAG in all
genotypes (Figure 4A and B). 
SAR7334 blocks the effects of OAG. 
Because  Gd3+ is  a  non-specific  sarcolemmal  cation  blocker,  to  further
characterize the mechanism for the increase in [Ca2+]i upon exposure to OAG, single
WT and MH muscle fibers isolated were incubated in 1µM SAR7334, which is a new
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more specific  blocker  of  TRPC6 and TRPC3 channels25 and then exposed to  OAG
(100µM). Pretreatment with SAR7334 significantly reduced the resting [Ca2+]i by 14% in
WT, 19% in MH-HET and 34% in MH-HOM, (Fig.  5A).  Furthermore,  SAR7334 also
prevented the OAG-mediated elevation of [Ca2+]i in all genotypes (Figure 5A). 
SAR7334 partially blocked the elevation of [Ca2+]i associated with MH episode 
Having observed inhibition of the OAG-induced increase in [Ca2+]i by SAR7334 in
WT and MH single muscle fibers, we then tested the activity of this TRPC3/6 channel
blocker during an MH episode. We, therefore, investigated the effect of SAR7334 on
[Ca2+]i in MH muscle  in vivo during exposure to 2% halothane.  [Ca
2+]i was measured
simultaneously in the right and left vastus lateralis muscles in WT and MH-HOM mice
before and after the addition of 2% halothane to their inspired gas (Insert Figure 4B).
The right vastus lateralis muscle was pretreated locally with 1 µM SAR7334 and the left
muscle served as the control. Figure 5B shows a typical in vivo experiment carried out
in an MH-HOM mouse. Prior to drug treatment [Ca2+]i was very similar in muscles from
both legs (265±9 nM left leg versus 275±9 nM right leg). 10 min after the application of
1µM SAR7334 on the exposed vastus lateralis fibers of the right leg reduced [Ca2+]i from
275±9 nM to 187±11 nM  (Figure 5B). Inhalation of halothane elicited an elevation of
[Ca2+]i in the untreated leg to 1,373±81 nM while in the SAR7334-treated leg the initial
increase in  [Ca2+]i was reduced by 62% (526±99 nM) after which  [Ca
2+]i  declined to
398±32nM (Figure 5B).  After 20 min of inhalation of halothane, the rectal temperature
reached 42º C, and the mouse died. 
Hyperforin induced elevation of [Ca2+]i and [Na
+]i 
Hyperforin  is  known  to  elevate  the  intracellular  concentration  of  Ca2+ through  the
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activation  of  DAG-sensitive  TRPC6  channels  without  activating  the  other  TRPC
isoforms (TRPC1, TRPC3, TRPC4, TRPC5, and TRPC7) 26. Hyperforin (5 µM) caused a
prominent sustained rise in [Ca2+]i, that was greater in MH (HOM>HET) than WT muscle
fibers (Figure 6A).  In WT muscle cells [Ca2+]i was enhanced by 21% upon incubation
with Hyperforin while in MH-HET it increased 43% and in MH-HOM by 64% (Figure 5A).
Removal of extracellular  Ca2+  reduced pre exposure [Ca2+]i and blocked the hyperforin
effect in all genotypes (Figure 6C). Similar to its effect on [Ca2+]i, hyperforin elevated
[Na+]i  in WT from 8±01 mM (n=15) to 9.5±0.6 mM (n=10) (p<0.001), in MH-HET from
10±0.9 mM (n=15)  (p<0.001) and in MH-HOM from 14.5±1.2 mM (n=11) to 20.3±1.6
mM (n=13) (p<0.001) (Figure 6B). 
Effects of genotype and sarcolemmal cation entry agonists and antagonists on
Mn2+ quench of Fura2 in differentiated myotubes
When the buffer was changed from imaging buffer to Mn2+ quench buffer baseline
quench  of  Fura2  fluorescence  was  observed  in  all  three  genotypes  (Figure  7A for
representative traces) with the median quench rate being greater in MH-HOM (-0.229
AFU/s Interquartile range (IQR) -0.129 to -0.378 AFU/s) versus MH-HET(-0.184 AFU/s,
IQR -0.105 to -0.32 AFU/s) and WT (-0.191 AFU/s, IQR -0.117 to -0.319 AFU/s) (Figure
7B). 
Qualitatively similar results were observed in isolated adult single muscle fibers
(data not shown).
We next determined the effect of sarcolemmal cation blockers 25 µM Gd3+ (a
nonspecific sarcolemmal cation entry blocker), and 250 nM SAR7334 (a TRPC specific
blocker) on the rate of Mn2+ quench of the fura2 fluorescence signal.  Treatment with 25
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µM Gd3+ profoundly blocked Mn2+ quench to near baseline levels in all three genotypes
(p<0.0001, n=65 – 96, Figure 6B). The reduction in the median quench rate was 88% in
WT (n=65), 100% in MH-HET (n=72) and 95.6% in MH-HOM (n= 96) (Figure 7B). After
treatment with 250nM SAR7334 in WT cells the change in median quench rate was not
significant  (8%,  p>0.999,  n  =  49),  while  MH-HET  and  in  MH-HOM  cells  there  was
significant  decrease (45%,  p<0.005, n = 53 and 69%, p<0.001, n = 35 for MH-HET and
MH-HOM respectively) in the median Mn2+ quench rate (Figure 7B).  
Protein expression differences in WT and MH muscle.
Western  blot  analysis  showed  that  TRPC3  and  TRPC6  were  significantly
increased in a gene dose dependent manner in MH muscles (HET (p<0.01) and HOM
(p<0.001) compared to WT. Figure 7A shows representative Western blot analysis of the
expression of TRPC3 and TRPC6 in WT and MH-Het and MH-HOM muscle; ß actin
was used as a loading control. Densitometric analysis of 5 independent Western blots
for each TRPC protein is shown in Figure 7B. 
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Discussion.-
The major findings of the present study are as follows. 
(1) We confirmed our previous finding9 that  RYR1-pG2435R muscle cells have
chronically elevated  intracellular resting [Ca2+]i and [Na+]i (HOM>HET) and
now  show  that  this  is  associated  with  elevated  Mn2+ quench  indicating
increased sarcolemmal cation influx; 
(2) Compared to WT, incubation of MH muscle cells with OAG or the TRPC6
activator hyperforin significantly increased [Ca2+]i and [Na
+]i (HOM>HET); 
(3) Increases in [Ca2+]i and [Na
+]i induced by OAG are dependent on extracellular
Ca2+ and are blocked by the nonspecific sarcolemmal cation channel blocker
Gd3+; 
(4) The OAG-induced increase  in  [Ca2+]i, and [Na+]i could  be blocked by the
nonspecific sarcolemmal cation channel blocker Gd3+ as well as the specific
TRPC3  and  TRPC6 channel  blocker  SAR7334.  SAR7334  treatment  also
significantly  reduced  resting  [Ca2+]i and  [Na
+]i,  blocked  Mn2+ quench,  and
reduced the elevation of [Ca2+]i in MH fibers after exposure to halothane;
(5) The  observed  changes  in  the  above  RYR1-pG2434R  responses  were
accompanied by an increase in the protein expression of TRPC3, TRPC6 in
MH (HOM>HET) skeletal muscles compared to WT.
For some time it  has been thought that the mechanism behind the increased
resting [Ca2+]i in MH susceptible muscle is simply due to SR leak and that the massive
increase in muscle [Ca2+]i during an MH episode comes from and is maintained by SR
Ca2+ stores.  Based on  our  studies  in  other  MH animal  models we  have  previously
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suggested  that  sarcolemmal  cation  entry  channels  are  at  the  very  least,  significant
contributors to the chronically elevated [Ca2+]i  in quiescent MH muscles and myotubes
21-
22 and that they play a similarly significant role during a fulminant MH episode22. 
A primary finding was that in addition to increased resting [Ca2+]i , resting [Na
+]i is
also elevated in  RYR1-pG2435R muscle cells  (HOM>HET) compared to WT, both in
vitro and  in  vivo21-22.  This  suggests  that  at  least  one  source  of  Ca2+ could  be  the
extracellular pool and not the SR. In this study we confirmed this hypothesis showing
that incubation of muscle with Gd3+, a potent non-specific inhibitor of sarcolemmal cation
influx, significantly reduced the intracellular levels of both Na+ and Ca2+ and blocked
Mn2+ quench, a monitor of sarcolemmal cation entry.
DAG  is  a  second  messenger  involved  in  key  cellular  processes  in  skeletal
muscle and other excitable cells27. In addition to its role as a lipid second messenger to
recruit  protein  kinases C, it  also activates the DAG sensitive  TRPC3/6 subgroup of
TRPC channels which reside in the sarcolemma24,28. Here, for the first time in examining
MH muscle cation homeostasis, we utilized the membrane-permeable DAG analogue,
OAG to determine if  the pathway for sarcolemmal Na+ and Ca2+ influx was through
TRPC3 and TRPC629.  OAG induced an elevation in the resting [Ca2+]i and [Na
+]i in all
three genotypes, and this was greater in MH (HOM>HET) muscle than WT (Figures 2A
and 2B). The elevation of [Ca2+]i, and the increase in Mn
2+ quench elicited by OAG was
blocked either by removal of extracellular Ca2+ or by blocking sarcolemmal Ca2+ and Na+
entry with Gd3+ or SAR7334 (Figures 3, 4 and 6). These data rule out any possibility that
OAG increased [Ca2+]i by releasing Ca
2+ from intracellular stores, and confirmed that the
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source  of  the  increase  was  from  the  extracellular  space through  TRPC3/6  whose
expression we showed was upregulated in MH compared to WT muscles. 
Incubation of  WT and MH single muscle fibers with  SAR7334,  a much more
specific  blocker  of  TRPC6 and TRPC3 channels than gadolinium25,  reduced resting
[Ca2+]i  in MH cells (HOM<HET<WT) and blocked the effects of OAG on resting  [Ca
2+]i
and Mn2+ quench. Local application of SAR7334 directly to the superficial muscle fibers
in vivo reduced resting  [Ca2+]i  in MH-HOM fibers and partially inhibited the halothane-
induced increase in [Ca2+]i  in MH muscle cells. This finding in particular demonstrates
that during the MH episode there is an initial SR supported increase in [Ca2+]i which
soon appears to be quickly partially depleted, as demonstrated by the rapid fall in [Ca2+]i
from ~750nM to  ~400nM in  the  SAR7334 treated  leg  during  the  same time  [Ca2+]i
continues to increase to  1,373±81 nM and then plateaus in the non-treated leg. All of
these data together support the hypothesis that sarcolemmal Ca2+ entry plays a critical
role in maintaining the new [Ca2+]i steady-state that has been observed during an MH
crisis.  Furthermore the observed immediate [Ca2+]i elevation in the SAR7334 treated
leg, is most probably mediated by the RyR1 Ca2+ release from the SR and the decline in
the [Ca2+]i in this leg shows that due to Ca
2+ extrusion and blockade of sarcolemmal Ca2+
entry that this level cannot be maintained by SR Ca2+ cycling.
Consistent with the OAG-mediated elevation of [Ca2+]i and [Na
+]i in muscle cells
plus the ability of the TRPC specific blocker SAR7334 to block both the pharmacologic
and halothane induced increases in Ca2+,  we also demonstrated that  hyperforin,  an
activator of TRPC6 mediated inward cationic current26,31,32, mimicked the action of OAG
and its effect was greater in MH (HOM>HET) than WT muscle cells. As observed with
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OAG  activation  removal  of  extracellular  Ca2+ also  eliminated  the  hyperforin-elicited
increase in resting [Ca2+]i
31. The enhanced cation flux observed across the sarcolemma
in MH cells is consistent with the cell boundary theorem which states that the long term
steady state of the free [Ca2+]i inside cells must be driven by changes with the outside
through fluxes across the plasmalemma22,33.
In summary, these results demonstrated that mice expressing the RYR1 mutation
p.G2435R have an elevated resting skeletal muscle [Ca2+]i and [Na
+]i 
 and a significantly
enhanced extracellular Ca2+ dependent response to OAG and a TRPC6 activator. We
further  showed that  the OAG response could  be prevented by TRPC3 and TRPC6
channel blockers. These results provide further support to our working hypothesis  that
in response to partial  depletion of SR Ca2+ due to MH causing mutations in  RYR1,
TRPC3 and TRPC6 channels play a critical role in producing the intracellular Ca2+ and
Na+ overload both at rest and during the MH crisis.
21
References.-
1. Nelson  TE:  Malignant  hyperthermia:  a  pharmacogenetic  disease  of  Ca++
regulating proteins. Curr Mol Med 2002; 2: 347-69
2. Jurkat-Rott K, Lerche H, Lehmann-Horn F: Skeletal muscle channelopathies. J
Neurol 2002; 249: 1493-502
3. Groom L, Muldoon SM, Tang ZZ, Brandom BW, Bayarsaikhan M, Bina S, Lee
HS,  Qiu  X,  Sambuughin  N,  Dirksen  RT:  Identical  de  novo  mutation  in  the  type  1
ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in
two unrelated families. Anesthesiology 2011; 115: 938-45
4. Parness  J,  Bandschapp  O,  Girard  T:  The  myotonias  and  susceptibility  to
malignant hyperthermia. Anesth Analg 2009; 109: 1054-64
5. Litman  RS,  Rosenberg  H:  Malignant  hyperthermia:  update  on  susceptibility
testing. JAMA 2005; 293: 2918-24
6. Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P: Mutations in RYR1 in
malignant hyperthermia and central core disease. Hum Mutat 2006; 27: 977-89
7. Yang T, Riehl J, Esteve E, Matthaei KI, Goth S, Allen PD, Pessah IN, Lopez JR:
Pharmacologic and functional characterization of malignant hyperthermia in the R163C
RyR1 knock-in mouse. Anesthesiology 2006; 105: 1164-75
8. Chelu MG, Goonasekera SA, Durham WJ, Tang W, Lueck JD, Riehl J, Pessah
IN,  Zhang  P,  Bhattacharjee  MB,  Dirksen  RT,  Hamilton  SL:  Heat-  and  anesthesia-
induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J 2006; 20: 329-
30
9. Lopez JR, Kaura V, Diggle CP, Hopkins PM, Allen PD: Malignant hyperthermia,
environmental heat stress, and intracellular calcium dysregulation in a mouse model
expressing the p.G2435R variant of RYR1. Br J Anaesth 2018; 121: 953-961
10. Du GG, Sandhu B, Khanna VK, Guo XH, MacLennan DH: Topology of the Ca2+
release channel of skeletal muscle sarcoplasmic reticulum (RyR1). Proc Natl Acad Sci
U S A 2002; 99: 16725-30
11. Miller DM, Daly C, Aboelsaod EM, Gardner L, Hobson SJ, Riasat K, Shepherd S,
Robinson RL, Bilmen JG, Gupta PK, Shaw MA, Hopkins PM: Genetic epidemiology of
malignant hyperthermia in the UK. Br J Anaesth 2018; 121: 944-952
12. Robinson RL, Brooks C, Brown SL, Ellis FR, Halsall PJ, Quinnell RJ, Shaw MA,
Hopkins PM: RYR1 mutations causing central core disease are associated with more
severe malignant hyperthermia in vitro contracture test phenotypes. Hum Mutat 2002;
20: 88-97
13. Carpenter D, Robinson RL, Quinnell RJ, Ringrose C, Hogg M, Casson F, Booms
P, Iles DE, Halsall PJ, Steele DS, Shaw MA, Hopkins PM: Genetic variation in RYR1
and malignant hyperthermia phenotypes. Br J Anaesth 2009; 103: 538-48
14. Lopez  JR,  Alamo L,  Caputo  C,  DiPolo  R,  Vergara  S:  Determination  of  ionic
calcium in frog skeletal muscle fibers. Biophys J 1983; 43: 1-4
15. Lopez JR, Alamo LA, Jones DE, Papp L, Allen PD, Gergely J, Sreter FA: [Ca2+]i
in muscles of malignant hyperthermia susceptible pigs determined in vivo with Ca2+
selective microelectrodes. Muscle Nerve 1986; 9: 85-6
22
16. Yang T, Esteve E, Pessah IN, Molinski TF, Allen PD, Lopez JR: Elevated resting
[Ca(2+)](i)  in  myotubes  expressing malignant  hyperthermia  RyR1 cDNAs is  partially
restored by modulation of passive calcium leak from the SR. Am J Physiol Cell Physiol
2007; 292: C1591-8
17. Eltit JM, Bannister RA, Moua O, Altamirano F, Hopkins PM, Pessah IN, Molinski
TF, Lopez JR, Beam KG, Allen PD: Malignant hyperthermia susceptibility arising from
altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type
1 ryanodine receptor. Proc Natl Acad Sci U S A 2012; 109: 7923-8
18. Feng W, Barrientos GC, Cherednichenko G, Yang T, Padilla IT, Truong K, Allen
PD, Lopez JR, Pessah IN: Functional and biochemical properties of ryanodine receptor
type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.
Mol Pharmacol 2011; 79: 420-31
19. Lopez JR, Allen PD, Alamo L, Jones D, Sreter FA: Myoplasmic free [Ca2+] during
a malignant hyperthermia episode in swine. Muscle Nerve 1988; 11: 82-8
20. Yuen B, Boncompagni S, Feng W, Yang T, Lopez JR, Matthaei  KI,  Goth SR,
Protasi F, Franzini-Armstrong C, Allen PD, Pessah IN: Mice expressing T4826I-RYR1
are  viable  but  exhibit  sex-  and  genotype-dependent  susceptibility  to  malignant
hyperthermia and muscle damage. FASEB J 2012; 26: 1311-22
21. Altamirano F, Eltit JM, Robin G, Linares N, Ding X, Pessah IN, Allen PD, Lopez
JR: Ca2+ influx via the Na+/Ca2+ exchanger is enhanced in malignant hyperthermia
skeletal muscle. J Biol Chem 2014; 289: 19180-90
22. Eltit JM, Ding X, Pessah IN, Allen PD, Lopez JR: Nonspecific sarcolemmal cation
channels are critical for the pathogenesis of malignant hyperthermia. FASEB J 2013;
27: 991-1000
23. Yang T, Allen PD, Pessah IN, Lopez JR: Enhanced excitation-coupled calcium
entry  in  myotubes  is  associated  with  expression  of  RyR1  malignant  hyperthermia
mutations. J Biol Chem 2007; 282: 37471-8
24. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G:
Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 1999;
397: 259-63
25. Maier T, Follmann M, Hessler G, Kleemann HW, Hachtel S, Fuchs B, Weissmann
N, Linz W, Schmidt T, Lohn M, Schroeter K, Wang L, Rutten H, Strubing C: Discovery
and  pharmacological  characterization  of  a  novel  potent  inhibitor  of  diacylglycerol-
sensitive TRPC cation channels. Br J Pharmacol 2015; 172: 3650-60
26. Leuner K, Kazanski V, Muller M, Essin K, Henke B, Gollasch M, Harteneck C,
Muller WE: Hyperforin--a key constituent of St. John's wort specifically activates TRPC6
channels. FASEB J 2007; 21: 4101-11
27. Bouron  A,  Chauvet  S,  Dryer  S,  Rosado  JA:  Second  Messenger-Operated
Calcium Entry Through TRPC6. Adv Exp Med Biol 2016; 898: 201-49
28. Gudermann T, Hofmann T, Mederos y Schnitzler M, Dietrich A: Activation, subunit
composition  and  physiological  relevance  of  DAG-sensitive  TRPC  proteins.  Novartis
Found Symp 2004; 258: 103-18; discussion 118-22, 155-9, 263-6
29. Tu P, Kunert-Keil C, Lucke S, Brinkmeier H, Bouron A: Diacylglycerol analogues
activate second messenger-operated calcium channels exhibiting TRPC-like properties
in cortical neurons. J Neurochem 2009; 108: 126-38
23
30. Lemos VS,  Poburko  D,  Liao  CH,  Cole  WC, van  Breemen  C:  Na+  entry  via
TRPC6 causes Ca2+ entry via NCX reversal in ATP stimulated smooth muscle cells.
Biochem Biophys Res Commun 2007; 352: 130-4
31. Leuner K, Li W, Amaral MD, Rudolph S, Calfa G, Schuwald AM, Harteneck C,
Inoue  T,  Pozzo-Miller  L:  Hyperforin  modulates  dendritic  spine  morphology  in
hippocampal  pyramidal  neurons  by  activating  Ca(2+)  -permeable  TRPC6  channels.
Hippocampus 2013; 23: 40-52
32. Treiber  K,  Singer  A,  Henke  B,  Muller  WE:  Hyperforin  activates  nonselective
cation channels (NSCCs). Br J Pharmacol 2005; 145: 75-83
33. Rios  E:  The  cell  boundary  theorem:  a  simple  law of  the  control  of  cytosolic
calcium concentration. J Physiol Sci 2010; 60: 81-4
24
Figure Legends.-
Figure 1. Elevated [Ca2+]i and [Na
+]i  in RyR1-G2435R MH muscle cells. [Ca
2+]i or
[Na+]i was measured in  quiescent  FDB fibers  isolated from WT, MH-HET,  and MH-
HOM mice(Fig. 1A) and in vivo from the vastus lateralis fibers in anesthetized WT and
MH  mice  (Fig.  1B) using  double-barreled  ion-specific  microelectrodes.  In  vitro
condition:  nmice=  3/experimental  condition,  ncell=  15-18/genotype  for  [Ca2+]i; nmice=
3/experimental  condition,  ncell  =  15-18/genotype  for  [Na+]i.  In  vivo condition:  nmice=
4/experimental  condition,  ncell =  13-16/genotype  for  [Ca2+]i; nmice=  5/experimental
condition,  ncell  = 8-11/ genotype for [Na+]i. Values are expressed as means ± S.D. for
each condition. One-way ANOVA with Tukey’s post-test, ***p0.001.
Figure 2. OAG provokes elevation of [Ca2+]i  and [Na
+]i.  Exposure of quiescent FDB
fibers  to 1-oleoyl-2-acetyl-sn-glycerol  (OAG)  100  µM  induced  an  elevation  of
[Ca2+]i (Fig.  2A)  and  [Na
+]i (Fig.  2B)  that  was  greater  in  MH (HOM>HET)  than WT
muscle fibers. Over the horizontal axis are indicated the experimental conditions used to
measure  [Ca2+]i  and  [Na
+]i. nmice=  3/experimental  condition,  ncell=  11-13/genotype  for
[Ca2+]i.  nmice=  3/experimental  condition,  ncell=  9-10/genotype  for  [Na
+]i. Values  are
expressed as means ± S.D. for each condition. One-way ANOVA with Tukey’s post-test,
***p0.001. 
Figure  3.  Removal  of  [Ca2+]e prevents  the  OAG-induced  increase  in  [Ca
2+]i.
Removal of extracellular Ca2+ lowered the [Ca2+]i and provoked the inhibition of OAG
(100 µM)-induced elevation of [Ca2+]i in FDB fibers isolated from WT, MH-HET, and MH-
HOM mice. On the horizontal axis are indicated the experimental conditions used to
measure [Ca2+]i. nmice= 3/experimental condition, ncell= 10-14/genotype for [Ca
2+]i. Values
are expressed as means ± S.D. for each condition. One-way ANOVA with Tukey’s post-
test, ***p0.001. 
Figure 4. Gd3+ abolishes the OAG effects on [Ca2+]i and [Na
+]i. Preincubation of WT,
MH-HET, and MH-HOM  FDB fibers  in  Gd3+  (25 µM) reduced the [Ca2+]i  and [Na
+]i  and
eliminated the increase in [Ca2+]i (Fig. 4A)  and [Na
+]i (Fig. 4B) induced by OAG. Over
the horizontal axis are indicated the experimental conditions used to measure [Ca2+]i
and  [Na+]i.  nmice=  4/experimental  condition,  ncell=  17-19/genotype  for  [Ca
2+]i.  nmice=
4/experimental  condition,  ncell=  13-15/genotype  for  [Na
+]i.  Values  are  expressed  as
means ± S.D. for each condition. One-way ANOVA with Tukey’s post-test, ***p0.001.
Figure 5. SAR7334 blocked the elevation of [Ca2+]i induced by OAG and partially
inhibits the increase associated with an MH episode. [Ca2+]i was measured WT, MH-
HET, and MH-HOM  FDB fibers before and after incubation in SAR7374 (1µM), as well
as  after  the  exposure  with  SAR7374  and  OAG  (100  µM).  Fig.  5A shows  that
preincubation in SAR7374 reduced [Ca2+]i  in all genotypes and prevent the increase in
intracellular  calcium  concentration  induced  by  OAG. Over  the  horizontal  axis  are
indicated the experimental conditions used to measure [Ca2+]i.  Fig. 5B shows a typical
experiment  carried  out  in  vivo  in   anesthetized  (ketamine/xylazine)  MH-HOM  mice.
[Ca2+]i was  measured  simultaneously  on  the  superficial  fibers  of  the vastus
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lateralis muscle in the right and left hind mice. Superficial muscle fibers were perfused
with Ringer solution alone (left leg, control, red line) or SAR7374 (1µM) for 5 min (right
leg, black line) and then the mouse was exposed to inhaled halothane 2% (black arrow).
The  insert  on  the  left  upper  corner  shows  the  experimental  arrangement:  1 and  2
calcium microelectrodes,  3 and  4 grounds,  5  rectal  temperature probe. For [Ca2+]i in
Fig.5A:  nmice=  4/experimental  condition,  ncell=  18-13/genotype.  For [Ca
2+]i in  Fig.5B:
nmice= 7. Values are expressed as means ± S.D. for each condition. One-way ANOVA
with Tukey’s post-test, ***p0.001.
Figure 6. Effect of hyperforin on [Ca2+]i. Hyperforin (5 µM) caused a sustained rise in
[Ca2+]i and [Na
+]i in single muscle fibers that were greater in MH (HOM>HET) than WT
(Fig. 6A and 6B). Removal of extracellular Ca2+ inhibited the hyperforin effect on [Ca2+]i
(Fig. 6C). On the horizontal axis are indicated the experimental conditions. For [Ca2+]i in
Fig. 6A: nmice= 3/experimental condition, ncell= 9/10 genotype. For [Na
+]i in Fig. 6B: nmice=
3/experimental  condition,  ncell=  15/10  genotype.  For  [Ca
2+]i in  Fig.  6C:  nmice=
3/experimental condition, ncell= 12/10 genotype. Values are expressed as means ± S.D.
for each condition. Paired and unpaired t-test and one-way ANOVA with Tukey’s post-
test, ***p0.001.
Figure  7:  Resting  sarcolemmal  divalent  cation  permeability  in  myotubes. (A)
Representative traces indicating the change in the rate of the fura2 fluorescence that
was quenched by Mn2+ in WT, MH-HET and HOM myotubes from RyR1-G2435R mice
upon changing from IB to MnB.  (B)  Box-plots showing the quench rate (median±Inter
Quartile Range) in control,  25 µM Gd3+ or 250 nM SAR7334 treated myotubes from
each of the three genotypes. The whiskers represent the 10-90th centile. A larger rate of
quench is represented by a more negative number and this indicates a greater cationic
entry through the sarcolemmal cation channels into the cell from the extracellular space
which  is  an  estimate  of  the  sarcolemmal  permeability  to  Ca2+.  p<0.05  in  MH-HOM
versus MH-HET and WT. **p<0.005 and  p<0.0001 in each genotype  vs. their control
conditions (Kruskall-Wallis test with Dunn's multiple comparisons test, n≥35 myotubes
for each condition). 
Figure  8. Fig.  8A shows  representative  Western  blots  showing  the  expression  of
TRPC3, TRPC6 and ß-actin in WT, MH-HET and MH-HOM gastrocnemius muscles.
Densitometric analysis of 5 independent Western blots for each TRPC protein is shown
in Fig. 8B. Data were normalized to ß-actin and are expressed as mean ± S.D. nmice=4.
Paired t-test, ** p0.01, ***p0.001
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